Background: This prespecified subgroup analysis of the FIDELIO-DKD trial aimed to evaluate the efficacy and safety of finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes melli
Background The Agatston score, commonly used to quantify coronary artery calcification (CAC), is determined by the plaque area and density. Despite an excellent predictability of the Agatston score fo
Legend: Unadjusted and adjusted hazard ratios (HR) and 95% Confidence Intervals (CI) for end-stage renal disease (ESRD) and death associated with 1 unit (µmol/L) change in homoarginine. (‡) Relative r
ABSTRACT Introduction: Digital radiography (DRx) may provide a suitable alternative to investigate mineral and bone disorder (MBD) and loss of bone density (BD) in rodent models of chronic kidney dise
